Why BGM Group Ltd.’s (BGM) Stock Is Up 8.27%
As of Friday, September 11, BGM Group Ltd.’s BGM share price has surged by 8.27%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a antitussive and expectorant medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes. Further, the company provides Fertilizer products comprising Xiongguan organic fertilizers to improve crop yield, increase soil’s chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers for plant growth. Additionally, it focuses on the AI-driven commercialization of DuXiaoBao platform to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers. BGM Group Ltd. is based in Chengdu, China.
Commentary & Analysis
Why BGM Group Ltd.’s (BGM) Stock Is Up 7.87%
As of Thursday, September 10, BGM Group Ltd.’s BGM share price has surged by 7.87%, which has investors questioning if this is right time to sell.Jenna Brashear
Why BGM Group Ltd.’s (BGM) Stock Is Up 10.53%
As of Wednesday, September 09, BGM Group Ltd.’s BGM share price has surged by 10.53%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why BGM Group Ltd.’s (BGM) Stock Is Up 5.23%
As of Tuesday, September 08, BGM Group Ltd.’s BGM share price has surged by 5.23%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why BGM Group Ltd.’s (BGM) Stock Is Down 7.04%
As of Thursday, September 03, BGM Group Ltd.’s BGM share price has dipped by 7.04%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Financial Summary
| Share Statistics | BGM | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $105.4 | $609.5 | 22% |
|
| Shares Out (Mil) | 185.6 | 43.4 | 75% |
|
| Institutional Ownership | 11.2% | 83.9% | 7% |
|
| Float (Mil) | 266.2 | 45.7 | 78% |
|
| Beta | na | 0.73 | na |
|
| Avg Daily Volume (000s) | 164 | 309 | 43% |
|
| Price Change (52-week) |
(96.2%) | 64.9% | 3% |
|
| Growth | BGM | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.7% | na |
|
| Net Income (5yr) | na | (1.6%) | na |
|
| EPS (5yr) | na | 15.1% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.0%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BGM | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $48 | $317 | 19% |
|
| Net Income (TTM) (Mil) | ($21) | ($11) | 23% |
|
| EPS (TTM) | ($0.111) | ($0.700) | 36% |
|
| Operating Cash Flow (TTM) (Mil) | $3 | ($7) | 35% |
|
| Net Cash Flow (TTM) (Mil) | $1 | $6 | 45% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 0% |
|
| Enterprise Value (Q1) (Mil) | $105 | $525 | 21% |
|
| Valuation | BGM | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.14 | 2.61 | 2% |
|
| P/E | na | 17.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BGM | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 16.9% | 68.8% | 17% |
|
| Net Margin | (44.2%) | 0.8% | 12% |
|
| ROA | (6.6%) | (22.7%) | 28% |
|
| ROE | (7.3%) | (22.8%) | 29% |
|
| Liabilities to Assets | 8.4% | 33.1% | 5% |
|
| F-Score | 2 | 3 | 7% |
|
BGM Group Ltd. did not pass any screens on 9/11/2026.
